Stada Claims A First With Ready-To-Use Bortezomib In Europe

Syringe
Stada's bortezomib adds value by employing a ready-to-use formulation • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Value Added Medicines

More from Products